Blockade of dopamine D1-like receptor signalling protects mice against OVA-induced acute asthma by inhibiting B-cell activating transcription factor signalling and Th17 function

FEBS Journal

Volumn 280, Issue 23, 2013, Pages 6262-6273

  Gong, Subo ^a   Li, Jinxiu ^a   Ma, Libing ^a   Li, Keng ^a   Zhang, Li ^a   Wang, Guyi ^a   Liu, Yi ^a   Ji, Xiaoying ^a   Liu, Xiaokun ^a   Chen, Ping ^a   Ouyang, Ruoyun ^a   Zhang, Shu ^b   Zhou, Zhiguang ^a   Wang, Cong Yi ^b,c   Xiang, Xudong ^a   Yang, Yu ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

asthma; B cell activating transcription factor; dopamine D1 like receptor; Th17 cells

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 (3 METHYLPHENYL) 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; B CELL ACTIVATING TRANSCRIPTION FACTOR; D1 LIKE RECEPTOR; DOPAMINE 1 RECEPTOR; OVALBUMIN; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TH17 CELL;

ASTHMA; B-CELL ACTIVATING TRANSCRIPTION FACTOR; DOPAMINE D1-LIKE RECEPTOR; TH17 CELLS;

ACUTE DISEASE; ANIMALS; ASTHMA; B-LYMPHOCYTES; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; BENZAZEPINES; BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE FLUID; CELL DIFFERENTIATION; CELL PROLIFERATION; DOPAMINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNOENZYME TECHNIQUES; LUNG; MICE; MICE, INBRED BALB C; OVALBUMIN; RECEPTORS, DOPAMINE D1; RNA, SMALL INTERFERING; TH17 CELLS;

MUS;

EID: 84888303048     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12549     Document Type: Article

References (42)

1. Iwakura Y, Nakae S, Saijo S, &, Ishigame H, (2008) The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol Rev 226, 57-79.
2. Wakashin H, Hirose K, Maezawa Y, Kagami S, Suto A, Watanabe N, Saito Y, Hatano M, Tokuhisa T, Iwakura Y, et al,. (2008) IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med 178, 1023-1032.
3. Schraml BU, Hildner K, Ise W, Lee WL, Smith WA, Solomon B, Sahota G, Sim J, Mukasa R, Cemerski S, et al,. (2009) The AP-1 transcription factor Batf controls T(H)17 differentiation. Nature 460, 405-409.
4. Nakano K, Higashi T, Hashimoto K, Takagi R, Tanaka Y, &, Matsushita S, (2008) Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis. Biochem Biophys Res Commun 373, 286-291.
5. Hashimoto K, Inoue T, Higashi T, Takei SI, Awata T, Katayama S, Takagi R, Okada H, &, Matsushita S, (2009) Dopamine D1-like receptor antagonist, SCH23390, exhibits a preventive effect on diabetes mellitus that occurs naturally in NOD mice. Biochem Biophys Res Commun 383, 460-463.
6. Zhen X, Uryu K, Wang H-Y, &, Friedman E, (1998) D1 dopamine receptor agonists mediate activation of p38 mitogen-activated protein kinase and c-Jun amino-terminal kinase by a protein kinase A-dependent mechanism in SK-N-MC human neuroblastoma cells. Mol Pharmacol 54, 453-458.
7. Mattson MP, Culmsee C, Yu Z, &, Camandola S, (2000) Roles of nuclear factor κB in neuronal survival and plasticity. J Neurochem 74, 443-456.
8. Olson CM, Hedrick MN, Izadi H, Bates TC, Olivera ER, &, Anguita J, (2007) p38 mitogen-activated protein kinase controls NF-κB transcriptional activation and tumor necrosis factor alpha production through RelA phosphorylation mediated by mitogen-and stress-activated protein kinase 1 in response to Borrelia burgdorferi antigens. Infect Immun 75, 270-277.
9. Li J, Peet GW, Balzarano D, Li X, Massa P, Barton RW, &, Marcu KB, (2001) Novel NEMO/IκB kinase and NF-κB target genes at the pre-B to immature B cell transition. J Biol Chem 276, 18579-18590.
10. Okada H, Inoue T, Hashimoto K, Suzuki H, &, Matsushita S, (2009) D1-like receptor antagonist inhibits IL-17 expression and attenuates crescent formation in nephrotoxic serum nephritis. Am J Nephrol 30, 274-279.
11. Nakashioya H, Nakano K, Watanabe N, Miyasaka N, Matsushita S, &, Kohsaka H, (2011) Therapeutic effect of D1-like dopamine receptor antagonist on collagen-induced arthritis of mice. Mod Rheumatol 21, 260-266.
12. Douwes J, Gibson P, Pekkanen J, &, Pearce N, (2002) Non-eosinophilic asthma: importance and possible mechanisms. Thorax 57, 643-648.
13. Zuhdi AM, Piazza FM, Selby DM, Letwin N, Huang L, &, Rose MC, (2000) Muc-5/5ac mucin messenger RNA and protein expression is a marker of goblet cell metaplasia in murine airways. Am J Respir Cell Mol Biol 22, 253.
14. + T cell-dependent airway mucus production occurs in response to IL-5 expression in lung. Am J Physiol Lung Cell Mol Physiol 282, L1066-L1074.
15. Dubucquoi S, Desreumaux P, Janin A, Klein O, Goldman M, Tavernier J, Capron A, &, Capron M, (1994) Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med 179, 703-708.
16. Schmid-Grendelmeier P, Altznauer F, Fischer B, Bizer C, Straumann A, Menz G, Blaser K, Wüthrich B, &, Simon H-U, (2002) Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J Immunol 169, 1021-1027.
17. Cohn L, Elias JA, &, Chupp GL, (2004) Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 22, 789-815.
18. Fernandes DJ, Mitchell RW, Lakser O, Dowell M, Stewart AG, &, Solway J, (2003) Invited review: do inflammatory mediators influence the contribution of airway smooth muscle contraction to airway hyperresponsiveness in asthma? J Appl Physiol 95, 844-853.
19. Rothenberg ME, &, Hogan SP, (2006) The eosinophil. Annu Rev Immunol 24, 147-174.
20. Gleich GJ, (2000) Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 105, 651-663.
21. Wills-Karp M, (2004) Interleukin-13 in asthma pathogenesis. Immunol Rev 202, 175-190.
22. Vargaftig BB, &, Singer M, (2003) Leukotrienes mediate murine bronchopulmonary hyperreactivity, inflammation, and part of mucosal metaplasia and tissue injury induced by recombinant murine interleukin-13. Am J Respir Cell Mol Biol 28, 410.
23. Nakagome K, Imamura M, Okada H, Kawahata K, Inoue T, Hashimoto K, Harada H, Higashi T, Takagi R, &, Nakano K, (2011) Dopamine D1-like receptor antagonist attenuates Th17-mediated immune response and ovalbumin antigen-induced neutrophilic airway inflammation. J Immunol 186, 5975-5982.
24. Liu AMF, Lo RKH, Wong CSS, Morris C, Wise H, &, Wong YH, (2006) Activation of STAT3 by G alpha(s) distinctively requires protein kinase A, JNK, and phosphatidylinositol 3-kinase. J Biol Chem 281, 35812-35825.
25. Senga T, Iwamoto T, Humphrey SE, Yokota T, Taparowsky EJ, &, Hamaguchi M, (2002) Stat3-dependent induction of BATF in M1 mouse myeloid leukemia cells. Oncogene 21, 8186-8191.
26. Nakano K, Higashi T, Takagi R, Hashimoto K, Tanaka Y, &, Matsushita S, (2009) Dopamine released by dendritic cells polarizes Th2 differentiation. Int Immunol 21, 645-654.
27. + regulatory T-cell activity: implications for neurodegeneration. Sci Signal 24, 6133.
28. Pacheco R, Riquelme E, &, Kalergis AM, (2010) Emerging evidence for the role of neurotransmitters in the modulation of T cell responses to cognate ligands. Cent Nerv Syst Agents Med Chem 10, 65-83.
29. + regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop. Blood 109, 632-642.
30. Besser MJ, Ganor Y, &, Levite M, (2005) Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFα or both. J Neuroimmunol 169, 161-171.
31. + T cells via dopamine receptor D3. J Immunol 176, 848-856.
32. Prado C, Contreras F, Gonzalez H, Diaz P, Elgueta D, Barrientos M, Herrada AA, Lladser A, Bernales S, &, Pacheco R, (2012) Stimulation of dopamine receptor D5 expressed on dendritic cells potentiates Th17-mediated immunity. J Immunol 188, 3062-3070.
33. Prado C, Bernales S, &, Pacheco R, (2013) Modulation of T-cell mediated immunity by dopamine receptor D5. Endocr Metab Immune Disord Drug Targets 13, 184-194.
34. Bourne JA, (2001) SCH 23390: the first selective dopamine D1-like receptor antagonist. CNS Drug Rev 7, 399-414.
35. Briggs CA, Pollock NJ, Frail DE, Paxson CL, Rakowski RF, Kang CH, &, Kebabian JW, (1991) Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393. Br J Pharmacol 104, 1038-1044.
36. Millan MJ, Newman-Tancredi A, Quentric Y, &, Cussac D, (2001) The "selective" dopamine D1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin2C receptors. Psychopharmacology 156, 58-62.
37. Mcmillan SJ, &, Lloyd CM, (2004) Prolonged allergen challenge in mice leads to persistent airway remodelling. Clin Exp Allergy 34, 497-507.
38. Bao Z, Lim S, Liao W, Lin Y, Thiemermann C, Leung BP, &, Wong WS, (2007) Glycogen synthase kinase-3beta inhibition attenuates asthma in mice. Am J Respir Crit Care Med 176, 431-438.
39. Wang Z, Zheng Y, Hou C, Yang L, Li X, Lin J, Huang G, Lu Q, Wang C-Y, &, Zhou Z, (2013) DNA methylation impairs TLR9 induced Foxp3 expression by attenuating IRF-7 binding activity in fulminant type 1 diabetes. J Autoimmun 41, 50-59.
40. Yang P, Zhang Y, Pang J, Zhang S, Yu Q, He L, Wagner K-U, Zhou Z, &, Wang C-Y, (2013) Loss of Jak2 impairs endothelial function by attenuating Raf-1/MEK1/Sp-1 signaling along with altered eNOS activities. Am J Pathol 183, 617-625.
41. Duan W, Chan JH, Wong CH, Leung BP, &, Wong WS, (2004) Anti-inflammatory effects of mitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model. J Immunol 172, 7053-7059.
42. Chu HY, Yang Z, Zhao B, Jin GZ, Hu GY, &, Zhen X, (2010) Activation of phosphatidylinositol-linked D1-like receptors increases spontaneous glutamate release in rat somatosensory cortical neurons in vitro. Brain Res 1343, 20-27.